Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
A study comparing the safety and efficacy of adalimumab compared with. placebo in adults with
inactive non-infectious intermediate uveitis, posterior uveitis, or panuveitis.